Every transformation begins with a clear vision and the courage to turn it into reality. At Newday, we bring together science, strategy, and creativity to accelerate innovation in health and wellbeing, advancing solutions that safeguard both people and the planet.
Founded by Dr. Sybille Buchwald-Werner, scientist, entrepreneur, and board leader, Newday unites deep expertise from the nutraceutical, pharmaceutical, and health-tech industries.
To shape a healthier, more sustainable future where science and purpose drive positive transformation for people, planet, and business.
To translate scientific insight into strategies and solutions that create measurable business value, human wellbeing, and environmental impact.
We work with companies, boards, and investors that integrate ESG and sustainability criteria into innovation and investment decisions, ensuring responsible growth and long-term resilience.
Together, we:
Newday’s expertise ranges from plant-based actives and natural materials to microbiome research and longevity science, bridging biological insight with technology to create evidence-based innovations for sustainable health.
Headquartered at the Life Science Center Düsseldorf, Newday operates globally, collaborating across Europe, the US, and Asia-Pacific. Our work spans market access, product design, board advisory, and ESG strategy. Guided by one belief: Science provides facts. Passion creates impact.
Because every breakthrough starts with a Newday®
At Newday, success is measured by transformation, of organizations, processes, and mindsets.
We prioritize partnerships and investments that align with our core values: scientific integrity, sustainability, and societal benefit. We believe capital should accelerate innovation that strengthens human health, protects the environment, and builds equitable futures.
As Qualified Person (QP) and GMP advisor for a leading German manufacturer of botanical APIs, Newday led the rollout of a company-wide GMP training program – including modules on hygiene, documentation (ALCOA principles), and deviation management. The initiative improved inspection readiness and established a strong culture of quality across production and laboratory teams.
Through international workshops and peer-reviewed research on AI & Nutraceuticals, Newday helps companies identify practical use cases for AI across product development, from consumer insight and health-benefit mapping to literature mining and market strategy. Participants gain clear roadmaps to integrate digital tools that accelerate innovation and reduce time-to-market.
Through board and committee work with Women in Nutraceuticals (WIN), Newday helps advance female representation in science-driven industries worldwide, supporting leadership programs, mentoring, and cross-regional collaboration in Europe, the US, and APAC.
Newday supports emerging and growth-stage companies in defining strategic pathways for expansion, funding, and venture readiness. Through structured business reviews, investor storytelling, and governance alignment, we help founders and executive teams transform scientific ideas into credible, investable business models.
Newday actively engages in initiatives that translate longevity science into societal value from early-stage venture support to thought leadership in science-to-society frameworks. We believe extending healthspan is not only a scientific pursuit but also a social responsibility enabling longer lives filled with vitality, purpose, and quality of life.
Newday continues to expand across health, science, and sustainability building bridges between evidence-based innovation and real-world impact. We are committed to creating meaningful change through sustainable partnerships, responsible innovation, and global collaboration, proving that transformation and sustainability can go hand in hand.
We believe that every project, no matter its scale, can inspire lasting change.
Every day is a Newday®
